Acceptance of Human Papillomavirus Vaccination in Postpartum Women (HPV Acceptance)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00730704|
Recruitment Status : Completed
First Posted : August 8, 2008
Last Update Posted : November 5, 2012
|Condition or disease|
|Human Papilloma Virus HPV Post Partum|
1. To estimate compliance with the HPV vaccine series when initiated in postpartum women.
- To determine patient acceptance and satisfaction with HPV vaccination administered in the postpartum period.
- To determine predictors of compliance with the HPV vaccination series.
|Study Type :||Observational|
|Actual Enrollment :||150 participants|
|Official Title:||Acceptance of Human Papillomavirus Vaccination in Postpartum Women|
|Study Start Date :||May 2009|
|Actual Primary Completion Date :||October 2012|
|Actual Study Completion Date :||October 2012|
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00730704
|United States, New York|
|Columbia University Medical Center|
|New York, New York, United States, 10032|
|Principal Investigator:||Jason Wright, MD||Columbia University|